Angileri L - Search Results

1

Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation.

Carlisi D, D'Anneo A, Angileri L, Lauricella M, Emanuele S, Santulli A, Vento R, Tesoriere G. Carlisi D, et al. Among authors: angileri l. J Cell Physiol. 2011 Jun;226(6):1632-41. doi: 10.1002/jcp.22494. J Cell Physiol. 2011. PMID: 21413021

2

The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation.

Carlisi D, Lauricella M, D'Anneo A, Emanuele S, Angileri L, Di Fazio P, Santulli A, Vento R, Tesoriere G. Carlisi D, et al. Among authors: angileri l. Eur J Cancer. 2009 Sep;45(13):2425-38. doi: 10.1016/j.ejca.2009.06.024. Epub 2009 Jul 28. Eur J Cancer. 2009. PMID: 19643600

3

Which Factors Are Associated with Persistence of Depressive and Anxiety Symptoms in Patients Affected by Atopic Dermatitis despite 2-Year Treatment with Dupilumab?

Ferrucci SM, Tavecchio S, Ceresa A, Angileri L, Berti E, Marzano AV, Buoli M. Ferrucci SM, et al. Among authors: angileri l. J Clin Med. 2024 Mar 29;13(7):1980. doi: 10.3390/jcm13071980. J Clin Med. 2024. PMID: 38610745 Free PMC article.

4

Assessment of Patient-Reported Outcomes at 48 Months of Treatment with Dupilumab for Severe Atopic Dermatitis: A Single-Center Real-Life Experience with 126 Patients.

Barei F, Zussino M, Tavecchio S, Angileri L, Rizzo A, Calzari P, Marzano AV, Ferrucci S. Barei F, et al. Among authors: angileri l. Pharmaceuticals (Basel). 2024 Jan 16;17(1):117. doi: 10.3390/ph17010117. Pharmaceuticals (Basel). 2024. PMID: 38256950 Free PMC article.

5

Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?

Ferrucci SM, Tavecchio S, Nicolini G, Angileri L, Ceresa A, Del Tordello G, Berti E, Marzano AV, Buoli M. Ferrucci SM, et al. Among authors: angileri l. Int Clin Psychopharmacol. 2024 May 1;39(3):201-205. doi: 10.1097/YIC.0000000000000511. Epub 2023 Dec 22. Int Clin Psychopharmacol. 2024. PMID: 37781860 Free PMC article.

6

Peristomal Skin Complications: Detailed Analysis of a Web-Based Survey and Predictive Risk Factors.

Guerra E, Denti FC, Di Pasquale C, Caroppo F, Angileri L, Cioni M, Parodi A, Fortina AB, Ferrucci S, Burlando M. Guerra E, et al. Among authors: angileri l. Healthcare (Basel). 2023 Jun 21;11(13):1823. doi: 10.3390/healthcare11131823. Healthcare (Basel). 2023. PMID: 37444657 Free PMC article.

7

Female Sex Affects Respiratory Function and Exercise Ability in Patients Recovered from COVID-19 Pneumonia.

Spicuzza L, Campisi R, Alia S, Prestifilippo S, Giuffrida ML, Angileri L, Ciancio N, Vancheri C. Spicuzza L, et al. Among authors: angileri l. J Womens Health (Larchmt). 2023 Jan;32(1):18-23. doi: 10.1089/jwh.2022.0104. Epub 2022 Nov 25. J Womens Health (Larchmt). 2023. PMID: 36450116

8

Topical tacrolimus during systemic therapy for severe atopic dermatitis in the clinical practice.

Ferrucci SM, Angileri L, Marzano AV, Berti E, Tavecchio S. Ferrucci SM, et al. Among authors: angileri l. Eur Rev Med Pharmacol Sci. 2022 Apr;26(7):2518-2523. doi: 10.26355/eurrev_202204_28489. Eur Rev Med Pharmacol Sci. 2022. PMID: 35442467 Free article.

9

Effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis: a preliminary report of real-world data.

Ferrucci SM, Maronese CA, Tavecchio S, Angileri L, Genovese G, Marzano AV. Ferrucci SM, et al. Among authors: angileri l. Ital J Dermatol Venerol. 2022 Apr;157(2):211-213. doi: 10.23736/S2784-8671.21.07014-6. Ital J Dermatol Venerol. 2022. PMID: 35391535 No abstract available.

10

Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease.

Ferrucci S, Angileri L, Tavecchio S, Fumagalli S, Iurlo A, Cattaneo D, Marzano AV, Maronese CA. Ferrucci S, et al. Among authors: angileri l. J Dermatolog Treat. 2022 Aug;33(5):2587-2592. doi: 10.1080/09546634.2022.2049588. Epub 2022 Mar 9. J Dermatolog Treat. 2022. PMID: 35261333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page